The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes
Clinical Breast Cancer · 2024-07 · 24 (5) · 431-438
DOI: 10.1016/j.clbc.2024.02.013 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Breast Cancer, 2024-07. Verfasst von Reiki Nishimura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan. Electronic address:…. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan. Electronic address: nishirei@ymail.ne.jp.
- Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.
- Clinical Oncology and Pathology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.
- Pathology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.
Zitieren
APA
Nishimura, R., Fujiki, Y., Taira, T., Miyaki, T., Kanemitsu, S., Yotsumoto, D., Teraoka, M., Kawano, J., Gondo, N., Mitsueda, R., Baba, S., Ohi, Y., Rai, Y., Sagara, Y., & Sagara, Y. (2024). The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes. Clinical Breast Cancer, 24(5), 431-438. https://doi.org/10.1016/j.clbc.2024.02.013
Vancouver
Nishimura R, Fujiki Y, Taira T, Miyaki T, Kanemitsu S, Yotsumoto D, et al. The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes. Clinical Breast Cancer. 2024;24(5):431-438. doi:10.1016/j.clbc.2024.02.013
BibTeX
@article{Nishimura2024,
author = {Nishimura, Reiki and Fujiki, Yoshitaka and Taira, Tetsuhiko and Miyaki, Toshiko and Kanemitsu, Shuichi and Yotsumoto, Daisuke and Teraoka, Megumi and Kawano, Junko and Gondo, Naomi and Mitsueda, Reiko and Baba, Shinichi and Ohi, Yasuyo and Rai, Yoshiaki and Sagara, Yoshiaki and Sagara, Yasuaki},
title = {The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes},
journal = {Clinical Breast Cancer},
year = {2024},
volume = {24},
number = {5},
pages = {431--438},
doi = {10.1016/j.clbc.2024.02.013}
}
EUVIMED